• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

87.56 +4.69 (+5.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own ↗
Today 4:50 EDT
AI's next winners in healthcare could be companies like Eli Lilly and Twist Bioscience. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Twist Bioscience Director Sold 12,000 Shares. Here's What That Means for Investors. ↗
June 12, 2026
This synthetic DNA specialist, leveraging silicon chip technology, reported a notable insider sale amid a year of strong share gains. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Twist Bioscience's Chief Legal Officer Sold Over 14,000 Company Shares. What Does That Mean for Investors? ↗
June 06, 2026
This synthetic biology innovator, known for its DNA-based solutions, reported a notable insider sale amid a year of strong share gains. 
Via The Motley Fool
Topics Regulatory Compliance
Twist Bioscience TWST Q2 Fiscal 2026: Revenue Beat Offset by Wider EPS Miss ↗
May 04, 2026
Via Chartmill
TWIST BIOSCIENCE CORP (NASDAQ:TWST) Reports Mixed Q1 FY2026 Results with Revenue Beat and Wider Loss ↗
February 02, 2026
Via Chartmill
News headline image
Twist Biosciences' (TWST) CEO Sold 16,000 Shares for $1.1 Million ↗
June 04, 2026
This synthetic biology firm, known for silicon-based DNA synthesis, reported a notable insider sale following strong one-year share gains. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference
May 27, 2026
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
May 05, 2026
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist (TWST) Q2 2026 Earnings Call Transcript ↗
May 04, 2026
Twist (TWST) Q2 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
Twist (TWST) Q3 2025 Earnings Transcript ↗
May 04, 2026
Twist (TWST) Q3 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences
May 04, 2026
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results
May 04, 2026
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026
April 21, 2026
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Upcoming Investor Conferences
February 18, 2026
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement
February 17, 2026
From Twist Bioscience Corporation
Via Business Wire
News headline image
Biotech Beat Nvidia in 2025. Can It Do It Again? ↗
February 11, 2026
Big pharma and biotech take the earnings stage with reports from Eli Lilly and Novo Nordisk leading the lineup. Will they help the industry once again outperform AI champ Nvidia? 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
February 10, 2026
From Twist Bioscience Corporation
Via Business Wire
News headline image
Cold Chain, High Stakes: A Deep Dive into Azenta’s (AZTA) Life Sciences Transformation
February 05, 2026
Date: February 5, 2026 Introduction In the high-stakes world of life sciences, the "cold chain" is the invisible backbone of modern medicine. From the development of mRNA vaccines to the emerging... 
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
February 03, 2026
From Twist Bioscience Corporation
Via Business Wire
News headline image
TWST Shares Rise 8% — What’s Driving The Rally? ↗
February 02, 2026
Twist Bioscience Corporation hiked its fiscal year 2026 revenue guidance on the heels of a first quarter earnings report that beat Wall Street estimates. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Twist Bioscience Q1 2026 Earnings Call Transcript ↗
February 02, 2026
Twist Bioscience Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results
February 02, 2026
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
January 12, 2026
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference
December 18, 2025
From Twist Bioscience Corporation
Via Business Wire
News headline image
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
December 12, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
December 04, 2025
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses ↗
November 14, 2025
Twist Bioscience reports mixed Q4 earnings with a loss of 45 cents, sales of $99.01 million beating consensus. 
Via Benzinga
News headline image
Twist Bioscience Corp (NASDAQ:TWST) Stock Falls After Q4 Earnings Miss ↗
November 14, 2025
Twist Bioscience Q4 2025 earnings miss analyst estimates on revenue and EPS, triggering a sharp pre-market stock decline. 
Via Chartmill
Topics Earnings
News headline image
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results
November 14, 2025
From Twist Bioscience Corporation
Via Business Wire
News headline image
Earnings Scheduled For November 14, 2025 ↗
November 14, 2025
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap